350 related articles for article (PubMed ID: 34862118)
1. Nanoparticle theranostics in cardiovascular inflammation.
MacRitchie N; Di Francesco V; Ferreira MFMM; Guzik TJ; Decuzzi P; Maffia P
Semin Immunol; 2021 Aug; 56():101536. PubMed ID: 34862118
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle Diagnostics and Theranostics in the Clinic.
Pallares RM; Mottaghy FM; Schulz V; Kiessling F; Lammers T
J Nucl Med; 2022 Dec; 63(12):1802-1808. PubMed ID: 36302654
[TBL] [Abstract][Full Text] [Related]
3. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.
Bejarano J; Navarro-Marquez M; Morales-Zavala F; Morales JO; Garcia-Carvajal I; Araya-Fuentes E; Flores Y; Verdejo HE; Castro PF; Lavandero S; Kogan MJ
Theranostics; 2018; 8(17):4710-4732. PubMed ID: 30279733
[TBL] [Abstract][Full Text] [Related]
5. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases.
Wu Y; Vazquez-Prada KX; Liu Y; Whittaker AK; Zhang R; Ta HT
Nanotheranostics; 2021; 5(4):499-514. PubMed ID: 34367883
[TBL] [Abstract][Full Text] [Related]
7. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
Tripathi P; Shukla P; Bieberich E
Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
[TBL] [Abstract][Full Text] [Related]
8. Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging.
Fernandes DA
Technol Cancer Res Treat; 2023; 22():15330338231191493. PubMed ID: 37642945
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
Mohammadi M; Ramezani M; Abnous K; Alibolandi M
Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
11. Magnetic mediators for ultrasound theranostics.
Józefczak A; Kaczmarek K; Bielas R
Theranostics; 2021; 11(20):10091-10113. PubMed ID: 34815806
[TBL] [Abstract][Full Text] [Related]
12. Theranostic nanoparticles for the management of thrombosis.
Russell P; Hagemeyer CE; Esser L; Voelcker NH
Theranostics; 2022; 12(6):2773-2800. PubMed ID: 35401833
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine strategies for molecular targets with MRI and optical imaging.
Pan D; Caruthers SD; Chen J; Winter PM; SenPan A; Schmieder AH; Wickline SA; Lanza GM
Future Med Chem; 2010 Mar; 2(3):471-90. PubMed ID: 20485473
[TBL] [Abstract][Full Text] [Related]
14. Treatment of atherosclerotic plaque: perspectives on theranostics.
Zhang Y; Koradia A; Kamato D; Popat A; Little PJ; Ta HT
J Pharm Pharmacol; 2019 Jul; 71(7):1029-1043. PubMed ID: 31025381
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in nanotheranostics for triple negative breast cancer treatment.
Thakur V; Kutty RV
J Exp Clin Cancer Res; 2019 Oct; 38(1):430. PubMed ID: 31661003
[TBL] [Abstract][Full Text] [Related]
16. PRINT: a novel platform toward shape and size specific nanoparticle theranostics.
Perry JL; Herlihy KP; Napier ME; Desimone JM
Acc Chem Res; 2011 Oct; 44(10):990-8. PubMed ID: 21809808
[TBL] [Abstract][Full Text] [Related]
17. Conjugated Polymer Nanoparticles for Tumor Theranostics.
Li T; Wu M; Wei Q; Xu D; He X; Wang J; Wu J; Chen L
Biomacromolecules; 2023 May; 24(5):1943-1979. PubMed ID: 37083404
[TBL] [Abstract][Full Text] [Related]
18. An Assessment of In-vitro and In-vivo Evaluation Methods for Theranostic Nanomaterials.
Parashar P; Singh N; Alka ; Maurya P; Saraf SA
Curr Pharm Des; 2022; 28(2):78-90. PubMed ID: 34348616
[TBL] [Abstract][Full Text] [Related]
19. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.
Wang S; He H; Mao Y; Zhang Y; Gu N
Adv Sci (Weinh); 2024 May; 11(17):e2308298. PubMed ID: 38368274
[TBL] [Abstract][Full Text] [Related]
20. Theranostic nanoparticles for cancer and cardiovascular applications.
Wang D; Lin B; Ai H
Pharm Res; 2014 Jun; 31(6):1390-406. PubMed ID: 24595494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
